The DOI matches its Crossref record; 279 of the 279 references it cites were found in a registry or an index.
Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification
Open accessAbstract
Next-generation sequencing (NGS) technology has expanded in the last decades with significant improvements in the reliability, sequencing chemistry, pipeline analyses, data interpretation and costs. Such advances make the use of NGS feasible in clinical practice today. This review describes the recent technological developments in NGS applied to the field of oncology. A number of clinical applications are reviewed, i.e., mutation detection in inherited cancer syndromes based on DNA-sequencing, detection of spliceogenic variants based on RNA-sequencing, DNA-sequencing to identify risk modifiers and application for pre-implantation genetic diagnosis, cancer somatic mutation analysis, pharmacogenetics and liquid biopsy. Conclusive remarks, clinical limitations, implications and ethical considerations that relate to the different applications are provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
The Human Genome Browser at UCSC
Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., & Haussler, A. D. (2002) · Genome Research · doi:10.1101/gr.229102 · Cited by 10,400
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Comprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Coming of age: ten years of next-generation sequencing technologies
Goodwin, S., McPherson, J. D., & McCombie, W. R. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.49 · Cited by 4,352
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Comprehensive genomic characterization of head and neck squamous cell carcinomas
The Cancer Genome Atlas Network (2015) · Nature · doi:10.1038/nature14129 · Cited by 3,877
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,449
Genomic classification of cutaneous melanoma
Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
The Cancer Genome Atlas Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402121 · Cited by 3,148
The Molecular Taxonomy of Primary Prostate Cancer
Abeshouse, A., Ahn, J., Akbani, R., Ally, A., Amin, S., Andry, C. D., Annala, M., Aprikian, A., Armenia, J., Arora, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.025 · Cited by 3,110
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Agrawal, N., Akbani, R., Aksoy, B. A., Ally, A., Arachchi, H., Asa, S. L., Auman, J. T., Balasundaram, M., Balu, S., Baylin, S. B., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.050 · Cited by 3,062
Comprehensive molecular characterization of urothelial bladder carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/za09-dk57 · Cited by 2,990
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
International network of cancer genome projects
The International Cancer Genome Consortium (2010) · Nature · doi:10.1038/nature08987 · Cited by 2,299
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219
Ceccarelli, M., Barthel, F. P., Malta, T. M., Sabedot, T. S., Salama, S. R., Murray, B. A., Morozova, O., Newton, Y., Radenbaugh, A., Pagnotta, S. M., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.028 · Cited by 2,189
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
Ross-Innes, C. S., Stark, R., Teschendorff, A. E., Holmes, K. A., Ali, H. R., Dunning, M. J., Brown, G. D., Gojis, O., Ellis, I. O., Green, A. R., et al. (2012) · Nature · doi:10.1038/nature10730 · Cited by 2,173
Frampton, G. M., Fichtenholtz, A., Otto, G. A., Wang, K., Downing, S. R., He, J., Schnall-Levin, M., White, J., Sanford, E. M., An, P., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2696 · Cited by 2,157
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Mutational Processes Molding the Genomes of 21 Breast Cancers
Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.024 · Cited by 1,909
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Ciriello, G., Gatza, M. L., Beck, A. H., Wilkerson, M. D., Rhie, S. K., Pastore, A., Zhang, H., McLellan, M., Yau, C., Kandoth, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.033 · Cited by 1,858
Pharmacogenomics Knowledge for Personalized Medicine
Whirl-Carrillo, M., McDonagh, E. M., Hebert, J. M., Gong, L., Sangkuhl, K., Thorn, C. F., Altman, R. B., & Klein, T. E. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.96 · Cited by 1,796
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789
The landscape of cancer genes and mutational processes in breast cancer
The Oslo Breast Cancer Consortium (OSBREAC), Stephens, P. J., Tarpey, P. S., Davies, H., Van Loo, P., Greenman, C., Wedge, D. C., Nik-Zainal, S., Martin, S., Varela, I., et al. (2012) · Nature · doi:10.1038/nature11017 · Cited by 1,698
Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification
Handyside, A. H., Kontogianni, E. H., Hardy, K., & Winston, R. M. L. (1990) · Nature · doi:10.1038/344768a0 · Cited by 1,604
The origin and evolution of mutations in acute myeloid leukemia
Welch, J. S., Ley, T. J., Link, D. C., Miller, C. A., Larson, D. E., Koboldt, D. C., Wartman, L. D., Lamprecht, T. L., Liu, F., Xia, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.023 · Cited by 1,575
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
Ley, T. J., Mardis, E. R., Ding, L., Fulton, B., McLellan, M. D., Chen, K., Dooling, D., Dunford-Shore, B. H., McGrath, S., Hickenbotham, M., et al. (2008) · Nature · doi:10.1038/nature07485 · Cited by 1,422
Differential Oestrogen Receptor Binding is Associated with Clinical Outcome in Breast Cancer
Stark, R. (2012) · Lecture Notes in Computer Science · doi:10.1007/978-3-642-29627-7_30 · Cited by 1,403
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
The Cancer Genome Atlas Research Network (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505917 · Cited by 1,336
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
Forshew, T., Murtaza, M., Parkinson, C., Gale, D., Tsui, D. W. Y., Kaper, F., Dawson, S.-J., Piskorz, A. M., Jimenez-Linan, M., Bentley, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003726 · Cited by 1,297
Sultan, M., Schulz, M. H., Richard, H., Magen, A., Klingenhoff, A., Scherf, M., Seifert, M., Borodina, T., Soldatov, A., Parkhomchuk, D., et al. (2008) · Science · doi:10.1126/science.1160342 · Cited by 1,293
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J. S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103283 · Cited by 1,222
Human Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays
Drmanac, R., Sparks, A. B., Callow, M. J., Halpern, A. L., Burns, N. L., Kermani, B. G., Carnevali, P., Nazarenko, I., Nilsen, G. B., Yeung, G., et al. (2010) · Science · doi:10.1126/science.1181498 · Cited by 1,212
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Shah, S. P., Morin, R. D., Khattra, J., Prentice, L., Pugh, T., Burleigh, A., Delaney, A., Gelmon, K., Guliany, R., Senz, J., et al. (2009) · Nature · doi:10.1038/nature08489 · Cited by 1,069
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
The Breast and Ovarian Cancer Susceptibility Collaboration, Michailidou, K., Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), kConFab Investigators, Australian Ovarian Cancer Study Group, The GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network, Hall, P., Gonzalez-Neira, A., Ghoussaini, M., Dennis, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2563 · Cited by 1,069
A small-cell lung cancer genome with complex signatures of tobacco exposure
Pleasance, E. D., Stephens, P. J., O’Meara, S., McBride, D. J., Meynert, A., Jones, D., Lin, M.-L., Beare, D., Lau, K. W., Greenman, C., et al. (2010) · Nature · doi:10.1038/nature08629 · Cited by 1,066
LOVD v.2.0: the next generation in gene variant databases
Fokkema, I. F. A. C., Taschner, P. E. M., Schaafsma, G. C. P., Celli, J., Laros, J. F. J., & den Dunnen, J. T. (2011) · Human Mutation · doi:10.1002/humu.21438 · Cited by 1,048
Stem cell transcriptome profiling via massive-scale mRNA sequencing
Cloonan, N., Forrest, A. R. R., Kolle, G., Gardiner, B. B. A., Faulkner, G. J., Brown, M. K., Taylor, D. F., Steptoe, A. L., Wani, S., Bethel, G., et al. (2008) · Nature Methods · doi:10.1038/nmeth.1223 · Cited by 1,035
Pharmacogenetics: From Bench to Byte— An Update of Guidelines
Swen, J. J., Nijenhuis, M., de Boer, A., Grandia, L., Maitland-van der Zee, A. H., Mulder, H., Rongen, G. A. P. J. M., van Schaik, R. H. N., Schalekamp, T., Touw, D. J., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.34 · Cited by 1,018
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
The Breast Cancer Susceptibility Collaboration (UK), Rahman, N., Seal, S., Thompson, D., Kelly, P., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., et al. (2007) · Nature Genetics · doi:10.1038/ng1959 · Cited by 1,003
The CORGI Consortium, Palles, C., The WGS500 Consortium, Cazier, J.-B., Howarth, K. M., Domingo, E., Jones, A. M., Broderick, P., Kemp, Z., Spain, S. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2503 · Cited by 997
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
Mavaddat, N., Peock, S., Frost, D., Ellis, S., Platte, R., Fineberg, E., Evans, D. G., Izatt, L., Eeles, R. A., Adlard, J., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt095 · Cited by 951
Walsh, T., Casadei, S., Lee, M. K., Pennil, C. C., Nord, A. S., Thornton, A. M., Roeb, W., Agnew, K. J., Stray, S. M., Wickramanayake, A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115052108 · Cited by 933
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Easton, D. F., Pharoah, P. D. P., Antoniou, A. C., Tischkowitz, M., Tavtigian, S. V., Nathanson, K. L., Devilee, P., Meindl, A., Couch, F. J., Southey, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1501341 · Cited by 920
Anchored multiplex PCR for targeted next-generation sequencing
Zheng, Z., Liebers, M., Zhelyazkova, B., Cao, Y., Panditi, D., Lynch, K. D., Chen, J., Robinson, H. E., Shim, H. S., Chmielecki, J., et al. (2014) · Nature Medicine · doi:10.1038/nm.3729 · Cited by 915
Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome
Hearle, N., Schumacher, V., Menko, F. H., Olschwang, S., Boardman, L. A., Gille, J. J. P., Keller, J. J., Westerman, A. M., Scott, R. J., Lim, W., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0083 · Cited by 855
Complex landscapes of somatic rearrangement in human breast cancer genomes
Stephens, P. J., McBride, D. J., Lin, M.-L., Varela, I., Pleasance, E. D., Simpson, J. T., Stebbings, L. A., Leroy, C., Edkins, S., Mudie, L. J., et al. (2009) · Nature · doi:10.1038/nature08645 · Cited by 845
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Davis, C. F., Ricketts, C. J., Wang, M., Yang, L., Cherniack, A. D., Shen, H., Buhay, C., Kang, H., Kim, S. C., Fahey, C. C., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.014 · Cited by 842
Improving genetic diagnosis in Mendelian disease with transcriptome sequencing
Cummings, B. B., Marshall, J. L., Tukiainen, T., Lek, M., Donkervoort, S., Foley, A. R., Bolduc, V., Waddell, L. B., Sandaradura, S. A., O’Grady, G. L., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal5209 · Cited by 831
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Jones, S., Hruban, R. H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D. W., Lin, J. C.-H., Palmisano, E., Brune, K., Jaffee, E. M., et al. (2009) · Science · doi:10.1126/science.1171202 · Cited by 826
Campbell, P. J., Stephens, P. J., Pleasance, E. D., O'Meara, S., Li, H., Santarius, T., Stebbings, L. A., Leroy, C., Edkins, S., Hardy, C., et al. (2008) · Nature Genetics · doi:10.1038/ng.128 · Cited by 824
Epigenetics in Alternative Pre-mRNA Splicing
Luco, R. F., Allo, M., Schor, I. E., Kornblihtt, A. R., & Misteli, T. (2011) · Cell · doi:10.1016/j.cell.2010.11.056 · Cited by 796
Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303108 · Cited by 784
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles
The Breast Cancer Susceptibility Collaboration (UK), Renwick, A., Thompson, D., Seal, S., Kelly, P., Chagtai, T., Ahmed, M., North, B., Jayatilake, H., Barfoot, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1837 · Cited by 743
Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. F., & Krainer, A. R. (2011) · Nature · doi:10.1038/nature10485 · Cited by 741
Signatures of mutation and selection in the cancer genome
Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P., Edkins, S., Andrews, J. M., Buck, G., Chen, L., Beare, D., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08768 · Cited by 707
Clinical assessment incorporating a personal genome
Ashley, E. A., Butte, A. J., Wheeler, M. T., Chen, R., Klein, T. E., Dewey, F. E., Dudley, J. T., Ormond, K. E., Pavlovic, A., Morgan, A. A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60452-7 · Cited by 674
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., Lerario, A. M., Else, T., Knijnenburg, T. A., Ciriello, G., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.002 · Cited by 657
Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations
Gonzalez, K. D., Noltner, K. A., Buzin, C. H., Gu, D., Wen-Fong, C. Y., Nguyen, V. Q., Han, J. H., Lowstuter, K., Longmate, J., Sommer, S. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6959 · Cited by 609
Forbes, S. A., Tang, G., Bindal, N., Bamford, S., Dawson, E., Cole, C., Kok, C. Y., Jia, M., Ewing, R., Menzies, A., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp995 · Cited by 573
van der Post, R. S., Vogelaar, I. P., Carneiro, F., Guilford, P., Huntsman, D., Hoogerbrugge, N., Caldas, C., Chelcun Schreiber, K. E., Hardwick, R. H., Ausems, M. G. E. M., et al. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103094 · Cited by 561
Study, C. (2008) · Nature Genetics · doi:10.1038/ng.262 · Cited by 558
High Cancer Risk in Peutz–Jeghers Syndrome: A Systematic Review and Surveillance Recommendations
van Lier, M. G. F., Wagner, A., Mathus-Vliegen, E. M. H., Kuipers, E. J., Steyerberg, E. W., & van Leerdam, M. E. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.725 · Cited by 542
Germline mutations in RAD51D confer susceptibility to ovarian cancer
Breast Cancer Susceptibility Collaboration (UK), Loveday, C., Turnbull, C., Ramsay, E., Hughes, D., Ruark, E., Frankum, J. R., Bowden, G., Kalmyrzaev, B., Warren-Perry, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.893 · Cited by 534
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
Comino-Méndez, I., Gracia-Aznárez, F. J., Schiavi, F., Landa, I., Leandro-García, L. J., Letón, R., Honrado, E., Ramos-Medina, R., Caronia, D., Pita, G., et al. (2011) · Nature Genetics · doi:10.1038/ng.861 · Cited by 526
Liu, W., Dong, X., Mai, M., Seelan, R. S., Taniguchi, K., Krishnadath, K. K., Halling, K. C., Cunningham, J. M., Qian, C., Christensen, E., et al. (2000) · Nature Genetics · doi:10.1038/79859 · Cited by 510
Nikiforov, Y. E., Carty, S. E., Chiosea, S. I., Coyne, C., Duvvuri, U., Ferris, R. L., Gooding, W. E., Hodak, S. P., LeBeau, S. O., Ohori, N. P., et al. (2014) · Cancer · doi:10.1002/cncr.29038 · Cited by 500
Heitzer, E., Auer, M., Gasch, C., Pichler, M., Ulz, P., Hoffmann, E. M., Lax, S., Waldispuehl-Geigl, J., Mauermann, O., Lackner, C., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4140 · Cited by 497
Walsh, T., Lee, M. K., Casadei, S., Thornton, A. M., Stray, S. M., Pennil, C., Nord, A. S., Mandell, J. B., Swisher, E. M., & King, M.-C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007983107 · Cited by 487
Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications
Churi, C. R., Shroff, R., Wang, Y., Rashid, A., Kang, H. C., Weatherly, J., Zuo, M., Zinner, R., Hong, D., Meric-Bernstam, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115383 · Cited by 450
Caudle, K., Klein, T., Hoffman, J., Muller, D., Whirl-Carrillo, M., Gong, L., McDonagh, E., Sangkuhl, K., Thorn, C., Schwab, M., et al. (2014) · Current Drug Metabolism · doi:10.2174/1389200215666140130124910 · Cited by 446
Tung, N., Battelli, C., Allen, B., Kaldate, R., Bhatnagar, S., Bowles, K., Timms, K., Garber, J. E., Herold, C., Ellisen, L., et al. (2015) · Cancer · doi:10.1002/cncr.29010 · Cited by 430
Breast Cancer Risk Among Male BRCA1 and BRCA2 Mutation Carriers
Tai, Y. C., Domchek, S., Parmigiani, G., & Chen, S. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm203 · Cited by 430
A field guide to whole‐genome sequencing, assembly and annotation
Ekblom, R., & Wolf, J. B. W. (2014) · Evolutionary Applications · doi:10.1111/eva.12178 · Cited by 428
Martinez-Lopez, J., Lahuerta, J. J., Pepin, F., González, M., Barrio, S., Ayala, R., Puig, N., Montalban, M. A., Paiva, B., Weng, L., et al. (2014) · Blood · doi:10.1182/blood-2014-01-550020 · Cited by 425
Single-Cell Whole-Genome Amplification and Sequencing: Methodology and Applications
Huang, L., Ma, F., Chapman, A., Lu, S., & Xie, X. S. (2015) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025352 · Cited by 423
Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia
Faham, M., Zheng, J., Moorhead, M., Carlton, V. E. H., Stow, P., Coustan-Smith, E., Pui, C.-H., & Campana, D. (2012) · Blood · doi:10.1182/blood-2012-07-444042 · Cited by 423
Microsatellite Instability Detection by Next Generation Sequencing
Salipante, S. J., Scroggins, S. M., Hampel, H. L., Turner, E. H., & Pritchard, C. C. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.223677 · Cited by 399
Accurate identification of human Alu and non-Alu RNA editing sites
Ramaswami, G., Lin, W., Piskol, R., Tan, M. H., Davis, C., & Li, J. B. (2012) · Nature Methods · doi:10.1038/nmeth.1982 · Cited by 387
Haraldsdottir, S., Hampel, H., Tomsic, J., Frankel, W. L., Pearlman, R., de la Chapelle, A., & Pritchard, C. C. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.041 · Cited by 376
Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics.
van El, C. G., Cornel, M. C., Borry, P., Hastings, R. J., Fellmann, F., Hodgson, S. V., Howard, H. C., Cambon‐Thomsen, A., Knoppers, B. M., Meijers-Heijboer, H. E. J., et al. (2013) · Europe PMC (PubMed Central) · Cited by 370
Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing
Campbell, P. J., Pleasance, E. D., Stephens, P. J., Dicks, E., Rance, R., Goodhead, I., Follows, G. A., Green, A. R., Futreal, P. A., & Stratton, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801523105 · Cited by 365
Actionable exomic incidental findings in 6503 participants: challenges of variant classification
Amendola, L. M., Dorschner, M. O., Robertson, P. D., Salama, J. S., Hart, R., Shirts, B. H., Murray, M. L., Tokita, M. J., Gallego, C. J., Kim, D. S., et al. (2015) · Genome Research · doi:10.1101/gr.183483.114 · Cited by 363
Thompson, L. H. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.06.002 · Cited by 357
Vasen, H. F. A., Gruis, N. A., Frants, R. R., van der Velden, P. A., Hille, E. T. M., & Bergman, W. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000915)87:6<809::aid-ijc8>3.0.co;2-u · Cited by 347
Morin, R. D., Bainbridge, M., Fejes, A., Hirst, M., Krzywinski, M., Pugh, T. J., McDonald, H., Varhol, R., Jones, S. J. M., & Marra, M. A. (2008) · BioTechniques · doi:10.2144/000112900 · Cited by 342
LaDuca, H., Stuenkel, A. J., Dolinsky, J. S., Keiles, S., Tandy, S., Pesaran, T., Chen, E., Gau, C.-L., Palmaer, E., Shoaepour, K., et al. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.40 · Cited by 332
Singh, R. R., Patel, K. P., Routbort, M. J., Reddy, N. G., Barkoh, B. A., Handal, B., Kanagal-Shamanna, R., Greaves, W. O., Medeiros, L. J., Aldape, K. D., et al. (2013) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.05.003 · Cited by 311
Tang, W. K. B.-K., & Endrenyi, L. (1998) · Pharmacogenetics · doi:10.1097/00008571-199808000-00001 · Cited by 299
Susswein, L. R., Marshall, M. L., Nusbaum, R., Vogel Postula, K. J., Weissman, S. M., Yackowski, L., Vaccari, E. M., Bissonnette, J., Booker, J. K., Cremona, M. L., et al. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.166 · Cited by 287
Genome-wide association analysis identifies three new breast cancer susceptibility loci
Netherlands Collaborative Group on Hereditary Breast and Ovarian Cancer (HEBON), Ghoussaini, M., (FBCS), F. B. C. S., The Gene Environment Interaction of Breast Cancer in Germany (GENICA) Network, kConFab Investigators, Australian Ovarian Cancer Study Group, Fletcher, O., Michailidou, K., Turnbull, C., Schmidt, M. K., et al. (2012) · Nature Genetics · doi:10.1038/ng.1049 · Cited by 283
Jaeger, E., Leedham, S., Lewis, A., Segditsas, S., Becker, M., Cuadrado, P. R., Davis, H., Kaur, K., Heinimann, K., Howarth, K., et al. (2012) · Nature Genetics · doi:10.1038/ng.2263 · Cited by 276
Pritchard, C. C., Salipante, S. J., Koehler, K., Smith, C., Scroggins, S., Wood, B., Wu, D., Lee, M. K., Dintzis, S., Adey, A., et al. (2014) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.08.004 · Cited by 273
Sequencing quality assessment tools to enable data-driven informatics for high throughput genomics
Leggett, R. M., Ramirez-Gonzalez, R. H., Clavijo, B. J., Waite, D., & Davey, R. P. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00288 · Cited by 272
Zhang, B., Beeghly-Fadiel, A., Long, J., & Zheng, W. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70076-6 · Cited by 272
Sahm, F., Schrimpf, D., Jones, D. T. W., Meyer, J., Kratz, A., Reuss, D., Capper, D., Koelsche, C., Korshunov, A., Wiestler, B., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1519-8 · Cited by 271
Lebofsky, R., Decraene, C., Bernard, V., Kamal, M., Blin, A., Leroy, Q., Rio Frio, T., Pierron, G., Callens, C., Bieche, I., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.12.003 · Cited by 269
Castéra, L., Krieger, S., Rousselin, A., Legros, A., Baumann, J.-J., Bruet, O., Brault, B., Fouillet, R., Goardon, N., Letac, O., et al. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.16 · Cited by 262
Yurgelun, M. B., Allen, B., Kaldate, R. R., Bowles, K. R., Judkins, T., Kaushik, P., Roa, B. B., Wenstrup, R. J., Hartman, A.-R., & Syngal, S. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.006 · Cited by 260
Provenzale, D., Gupta, S., Ahnen, D. J., Bray, T., Cannon, J. A., Cooper, G., David, D. S., Early, D. S., Erwin, D., Ford, J. M., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0108 · Cited by 255
Points to consider in the clinical application of genomic sequencing
(2012) · Genetics in Medicine · doi:10.1038/gim.2012.74 · Cited by 249
Liang, H., Cheung, L. W. T., Li, J., Ju, Z., Yu, S., Stemke-Hale, K., Dogruluk, T., Lu, Y., Liu, X., Gu, C., et al. (2012) · Genome Research · doi:10.1101/gr.137596.112 · Cited by 241
Rothé, F., Laes, J.-F., Lambrechts, D., Smeets, D., Vincent, D., Maetens, M., Fumagalli, D., Michiels, S., Drisis, S., Moerman, C., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu288 · Cited by 233
Clinical next‐generation sequencing in patients with non–small cell lung cancer
Hagemann, I. S., Devarakonda, S., Lockwood, C. M., Spencer, D. H., Guebert, K., Bredemeyer, A. J., Al‐Kateb, H., Nguyen, T. T., Duncavage, E. J., Cottrell, C. E., et al. (2015) · Cancer · doi:10.1002/cncr.29089 · Cited by 230
Lentz, J. J., Jodelka, F. M., Hinrich, A. J., McCaffrey, K. E., Farris, H. E., Spalitta, M. J., Bazan, N. G., Duelli, D. M., Rigo, F., & Hastings, M. L. (2013) · Nature Medicine · doi:10.1038/nm.3106 · Cited by 229
Williamson, S. R., Eble, J. N., Amin, M. B., Gupta, N. S., Smith, S. C., Sholl, L. M., Montironi, R., Hirsch, M. S., & Hornick, J. L. (2015) · Modern Pathology · doi:10.1038/modpathol.2014.86 · Cited by 225
Dihydropyrimidine Dehydrogenase Gene as a Major Predictor of Severe 5-Fluorouracil Toxicity
Amstutz, U., Froehlich, T. K., & Largiadèr, C. R. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.72 · Cited by 217
Couraud, S., Vaca-Paniagua, F., Villar, S., Oliver, J., Schuster, T., Blanché, H., Girard, N., Trédaniel, J., Guilleminault, L., Gervais, R., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3063 · Cited by 215
Thompson, E. R., Doyle, M. A., Ryland, G. L., Rowley, S. M., Choong, D. Y. H., Tothill, R. W., Thorne, H., kConFab, Barnes, D. R., Li, J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002894 · Cited by 211
Harris, M. H., DuBois, S. G., Glade Bender, J. L., Kim, A., Crompton, B. D., Parker, E., Dumont, I. P., Hong, A. L., Guo, D., Church, A., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5689 · Cited by 206
Johnston, J. J., Rubinstein, W. S., Facio, F. M., Ng, D., Singh, L. N., Teer, J. K., Mullikin, J. C., & Biesecker, L. G. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.05.021 · Cited by 206
Lincoln, S. E., Kobayashi, Y., Anderson, M. J., Yang, S., Desmond, A. J., Mills, M. A., Nilsen, G. B., Jacobs, K. B., Monzon, F. A., Kurian, A. W., et al. (2015) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.04.009 · Cited by 205
Pritchard, C. C., Smith, C., Salipante, S. J., Lee, M. K., Thornton, A. M., Nord, A. S., Gulden, C., Kupfer, S. S., Swisher, E. M., Bennett, R. L., et al. (2012) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.03.002 · Cited by 204
Tan, M. C., Basturk, O., Brannon, R. A., Bhanot, U., Scott, S. N., Bouvier, N., LaFemina, J., Jarnagin, W. R., Berger, M. F., Klimstra, D., et al. (2015) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2014.11.029 · Cited by 203
Bao, R., Huang, L., Andrade, J., Tan, W., Kibbe, W. A., Jiang, H., & Feng, G. (2014) · Cancer Informatics · doi:10.4137/cin.s13779 · Cited by 197
Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinib
Patel, K. P., Newberry, K. J., Luthra, R., Jabbour, E., Pierce, S., Cortes, J., Singh, R., Mehrotra, M., Routbort, M. J., Luthra, M., et al. (2015) · Blood · doi:10.1182/blood-2015-03-633404 · Cited by 194
Natesan, S. A., Bladon, A. J., Coskun, S., Qubbaj, W., Prates, R., Munne, S., Coonen, E., Dreesen, J. C. F. M., Stevens, S. J. C., Paulussen, A. D. C., et al. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.45 · Cited by 191
Self-citationValidation of a Next-Generation Sequencing Assay for Clinical Molecular Oncology
Cottrell, C. E., Al-Kateb, H., Bredemeyer, A. J., Duncavage, E. J., Spencer, D. H., Abel, H. J., Lockwood, C. M., Hagemann, I. S., O’Guin, S. M., Burcea, L. C., et al. (2014) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.10.002 · Cited by 184
Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma‐Tailored Gene Panel
Zacher, A., Kaulich, K., Stepanow, S., Wolter, M., Köhrer, K., Felsberg, J., Malzkorn, B., & Reifenberger, G. (2017) · Brain Pathology · doi:10.1111/bpa.12367 · Cited by 181
Mackenzie, R., Kommoss, S., Winterhoff, B. J. N., Kipp, B. R., García, J. J., Voss, J. S., Halling, K. C., Karnezis, A. N., Senz, J., Yang, W., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1421-8 · Cited by 172
Accessing Genetic Information with Liquid Biopsies
Cai, X., Jankú, F., Zhan, Q., & Fan, J. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.06.001 · Cited by 168
Epigenetics Meets Genetics in Acute Myeloid Leukemia: Clinical Impact of a Novel Seven-Gene Score
Marcucci, G., Yan, P. S., Maharry, K. S., Frankhouser, D. E., Nicolet, D., Metzeler, K. H., Kohlschmidt, J., Mrózek, K., Wu, Y.-Z., Bucci, D. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.6337 · Cited by 167
Clinical Validation of KRAS, BRAF, and EGFR Mutation Detection Using Next-Generation Sequencing
Lin, M., Mosier, S. L., Thiess, M., Beierl, K. F., Debeljak, M., Tseng, L., Chen, G., Yegnasubramanian, S., Ho, H., Cope, L., et al. (2014) · American Journal of Clinical Pathology · doi:10.1309/ajcpmwgwgo34egod · Cited by 166
Sorber, L., Zwaenepoel, K., Deschoolmeester, V., Schil, P. E. V., van Meerbeeck, J. P., Lardon, F., Rolfo, C. D., & Pauwels, P. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.04.026 · Cited by 166
Guttery, D. S., Page, K., Hills, A., Woodley, L., Marchese, S. D., Rghebi, B., Hastings, R. K., Luo, J., Pringle, J. H., Stebbing, J., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.238717 · Cited by 164
Schwaederle, M. C., Husain, H., Fanta, P. T., Piccioni, D. E., Kesari, S., Schwab, R. B., Banks, K. C., Lanman, R. B., Talasaz, A. H., Parker, B. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7110 · Cited by 162
Lo Iacono, M., Monica, V., Righi, L., Grosso, F., Libener, R., Vatrano, S., Bironzo, P., Novello, S., Musmeci, L., Volante, M., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000436 · Cited by 161
Wautot, V., Vercherat, C., Lespinasse, J., Chambe, B., Lenoir, G. M., Zhang, C. X., Porchet, N., Cordier, M., Béroud, C., & Calender, A. (2002) · Human Mutation · doi:10.1002/humu.10092 · Cited by 160
Clinical and biological significance of circulating tumor cells in cancer
Masuda, T., Hayashi, N., Iguchi, T., Ito, S., Eguchi, H., & Mimori, K. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.010 · Cited by 159
Translatome profiling: methods for genome-scale analysis of mRNA translation
King, H. A., & Gerber, A. P. (2014) · Briefings in Functional Genomics · doi:10.1093/bfgp/elu045 · Cited by 156
Froehlich, T. K., Amstutz, U., Aebi, S. P., Joerger, M., & Largiadèr, C. R. (2014) · International Journal of Cancer · doi:10.1002/ijc.29025 · Cited by 155
Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients
Schwaederle, M. C., Husain, H., Fanta, P. T., Piccioni, D. E., Kesari, S., Schwab, R. B., Patel, S. P., Harismendy, O., Ikeda, M., Parker, B. A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0318 · Cited by 155
Marchetti, A., Grammastro, M. D., Felicioni, L., Malatesta, S., Filice, G., Centi, I., Pas, T. M. D., Santoro, A., Chella, A., Brandes, A. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103883 · Cited by 153
Concurrent Whole-Genome Haplotyping and Copy-Number Profiling of Single Cells
Esteki, M. Z., Dimitriadou, E., Mateiu, L. M., Melotte, C., der Aa, N. V., Kumar, P., Das, R., Theunis, K., Cheng, J., Legius, E., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.04.011 · Cited by 152
Weissman, S. M., Burt, R. W., Church, J. M., Erdman, S., Hampel, H., Holter, S., Jasperson, K. W., Kalady, M. F., Haidle, J. L., Lynch, H. T., et al. (2011) · Journal of Genetic Counseling · doi:10.1007/s10897-011-9465-7 · Cited by 152
Tsongalis, G. J., Peterson, J. D., Abreu, F. B. D., Tunkey, C. D., Gallagher, T. L., Strausbaugh, L. D., Wells, W. A., & Amos, C. I. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0883 · Cited by 149
Yan, L., Huang, L., Xu, L., Huang, J., Ma, F., Zhu, X., Tang, Y., Liu, M., Lian, Y., Liu, P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523297113 · Cited by 148
Smircich, P., Eastman, G., Bispo, S., Duhagon, M. A., Guerra-Slompo, E. P., Garat, B., Goldenberg, S., Munroe, D., Dallagiovanna, B., Holetz, F. B., et al. (2015) · BMC Genomics · doi:10.1186/s12864-015-1563-8 · Cited by 140
Price, M. J., Murray, S. S., Angiolillo, D. J., Lillie, E. O., Smith, E. N., Tisch, R. L., Schork, N. J., Teirstein, P. S., & Topol, E. J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.068 · Cited by 138
Bonnet, C., Krieger, S., Vézain, M., Rousselin, A., Tournier, I., Martins, A., Berthet, P., Chevrier, A., Dugast, C., Layet, V., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2007.056895 · Cited by 131
Familial melanoma, pancreatic cancer and germline CDKN2A mutations
Goldstein, A. M. (2004) · Human Mutation · doi:10.1002/humu.9247 · Cited by 130
Genome sequence–independent identification of RNA editing sites
Zhang, Q., & Xiao, X. G. (2015) · Nature Methods · doi:10.1038/nmeth.3314 · Cited by 129
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease
Lin, L., Park, J. W., Ramachandran, S. S., Zhang, Y., Tseng, Y., Shen, S., Waldvogel, H. J., Curtis, M. A., Faull, R. L. M., Troncoso, J. C., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw187 · Cited by 129
Gallego, C. J., Shirts, B. H., Bennette, C. S., Guzauskas, G. F., Amendola, L. M., Horike-Pyne, M. J., Hisama, F. M., Pritchard, C. C., Grady, W. M., Burke, W., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.3665 · Cited by 126
Duncavage, E. J., Magrini, V. J., Becker, N., Armstrong, J. R., Demeter, R., Wylie, T., Abel, H., & Pfeifer, J. D. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2011.01.006 · Cited by 124
Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2
Minion, L. E., Dolinsky, J. S., Chase, D. M., Dunlop, C. L. M., Chao, E., & Monk, B. J. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.01.537 · Cited by 121
Kraus, C. S., Hoyer, J., Vasileiou, G., Wunderle, M., Lux, M. P., Fasching, P. A., Krumbiegel, M., Uebe, S., Reuter, M. S., Beckmann, M. W., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30428 · Cited by 121
Harms, P. W., Collie, A. M. B., Hovelson, D. H., Cani, A. K., Verhaegen, M. E., Patel, R. M., Fullen, D. R., Omata, K., Dlugosz, A. A., Tomlins, S. A., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2015.154 · Cited by 120
Judkins, T., Leclair, B., Bowles, K., Gutin, N., Trost, J., McCulloch, J., Bhatnagar, S., Murray, A., Craft, J., Wardell, B., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1224-y · Cited by 118
Scarpa, A., Sikora, K. O., Fassan, M., Rachiglio, A. M., Cappellesso, R., Antonello, D., Amato, E., Mafficini, A., Lambiase, M., Esposito, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080478 · Cited by 116
Johnson, D. B., Dahlman, K. H., Knol, J., Gilbert, J., Puzanov, I. J., Means-Powell, J. A., Balko, J. M., Lovly, C. M., Murphy, B. A., Goff, L. W., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0011 · Cited by 116
A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees
Harland, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.23.2679 · Cited by 112
Dynamics and ethics of comprehensive preimplantation genetic testing: a review of the challenges
Hens, K., Dondorp, W., Handyside, A. H., Harper, J. C., Newson, A. J., Pennings, G., Rehmann‐Sutter, C., & de Wert, G. M. W. R. (2013) · Human Reproduction Update · doi:10.1093/humupd/dmt009 · Cited by 112
Marziali, A., & Akeson, M. A. (2001) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.3.1.195 · Cited by 112
Identification of Rad51 alteration in patients with bilateral breast cancer
Kato, M., Yano, K., Matsuo, F., Saito, H., Katagiri, T., Kurumizaka, H., Yoshimoto, M., Kasumi, F., Akiyama, F., Sakamoto, G., et al. (2000) · Journal of Human Genetics · doi:10.1007/s100380050199 · Cited by 110
Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment
Parker, B. C., & Zhang, W. (2013) · 癌症:英文版 · doi:10.5732/cjc.013.10178 · Cited by 110
Xu, S., Lou, F., Wu, Y., Sun, D., Zhang, J., Chen, W., Ye, H., Liu, J.-H., Wei, S., Zhao, M., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.005 · Cited by 108
Gracia-Aznárez, F. J., Fernández, M. V., Pita, G., Peterlongo, P., Domínguez, O., de la Hoya, M., Duran, M., Osório, A., Moreno, L. T., González‐Neira, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055681 · Cited by 107
Whole Genome Sequencing as a Diagnostic Test: Challenges and Opportunities
Chrystoja, C. C., & Diamandis, E. P. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.209213 · Cited by 107
Personalized Pharmacogenomics Profiling Using Whole-Genome Sequencing
Mizzi, C., Peters, B. A., Mitropoulou, C., Mitropoulos, K. A., Κάτσιλα, Θ., Agarwal, M. R., van Schaik, R. H., Drmanac, R., Borg, J., & Patrinos, G. P. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.102 · Cited by 106
Kidess, E., & Jeffrey, S. S. (2013) · Genome Medicine · doi:10.1186/gm474 · Cited by 104
Alonso‐Alconada, L., Muinelo‐Romay, L., Madissoo, K., Díaz‐López, A., Krakstad, C., Trovik, J., Wik, E., Hapangama, D. K., Coenegrachts, L., Cano, A., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-223 · Cited by 103
Self-citationde Leng, W. W. J., Hooijdonk, C. G. G., Barendregt-Smouter, F. A. S., Koudijs, M. J., Nijman, I., Hinrichs, J. W. J., Cuppen, E. P. J. G., van Lieshout, S., Loberg, R. D., de Jonge, M. J. A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149405 · Cited by 103
The AURORA initiative for metastatic breast cancer
Zardavas, D., Maetens, M., Irrthum, A., Goulioti, T., Engelen, K., Fumagalli, D., Salgado, R., Aftimos, P. G., Saini, K. S., Sotiriou, C. P., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.341 · Cited by 100
Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers
Milne, R. L., & Antoniou, A. C. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq660 · Cited by 100
Malapelle, U., Vigliar, E., Sgariglia, R., Bellevicine, C., Colarossi, L., Vitale, D., Pallante, P., & Troncone, G. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202691 · Cited by 99
BRCA2 T2722R Is a Deleterious Allele That Causes Exon Skipping
Fackenthal, J. D., Cartegni, L., Krainer, A. R., & Olopade, O. I. (2002) · The American Journal of Human Genetics · doi:10.1086/342192 · Cited by 98
Peng, S., Lü, B., Ruan, W., Zhu, Y., Sheng, H., & Lai, M. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1459-5 · Cited by 95
Tafe, L. J., Gorlov, I. P., Abreu, F. B. D., Lefferts, J. A., Liu, X., Pettus, J. R., Marotti, J. D., Bloch, K. J., Memoli, V. A., Suriawinata, A. A., et al. (2015) · The Oncologist · doi:10.1634/theoncologist.2015-0097 · Cited by 95
Improving performance of multigene panels for genomic analysis of cancer predisposition
Shirts, B. H., Casadei, S., Jacobson, A. L., Lee, M. K., Gülsüner, S., Bennett, R. L., Miller, M., Hall, S., Hampel, H., Hisama, F. M., et al. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.212 · Cited by 95
Schwaederle, M., Daniels, G. A., Piccioni, D. E., Fanta, P. T., Schwab, R. B., Shimabukuro, K. A., Parker, B. A., & Kurzrock, R. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-1061 · Cited by 90
Singh, R. R., Patel, K. P., Routbort, M. J., Aldape, K., Lu, X. Y., Manekia, J., Abraham, R., Reddy, N. G., Barkoh, B. A., Veliyathu, J., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.518 · Cited by 88
Uzilov, A. V., Ding, W., Fink, M. Y., Antipin, Y., Brohl, A. S., Davis, C., Lau, C. Y., Pandya, C., Shah, H., Kasai, Y., et al. (2016) · Genome Medicine · doi:10.1186/s13073-016-0313-0 · Cited by 87
Tran, B., Brown, A. M. K., Bedard, P. L., Winquist, E., Goss, G. D., Hotte, S. J., Welch, S. A., Hirte, H. W., Zhang, T., Stein, L. D., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27817 · Cited by 86
Braig, F., Voigtlaender, M., Schieferdecker, A., Busch, C., Laban, S. A., Grob, T. J., Kriegs, M., Knecht, R., Bokemeyer, C., & Binder, M. (2016) · Oncotarget · doi:10.18632/oncotarget.8943 · Cited by 86
Characterization of microRNA transcriptome in lung cancer by next‐generation deep sequencing
Ma, J., Mannoor, K., Gao, L., Tan, A., Guarnera, M. A., Zhan, M., Shetty, A. C., Stass, S. A., Xing, L., & Jiang, F. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.03.019 · Cited by 84
Al‐Kateb, H., Nguyen, T. T., Steger-May, K., & Pfeifer, J. D. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.05.004 · Cited by 84
Harper, J. C., Geraedts, J. P. M., Borry, P., Cornel, M. C., Dondorp, W., Gianaroli, L., Harton, G., Milachich, T., Kääriäinen, H. A., Liebaers, I., et al. (2014) · Human Reproduction · doi:10.1093/humrep/deu130 · Cited by 83
Renwick, P., Trussler, J., Lashwood, A., Braude, P., & Ogilvie, C. M. (2010) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2010.01.006 · Cited by 81
Dihydropyrimidinase deficiency: Phenotype, genotype and structural consequences in 17 patients
Kuilenburg, A. B. P., Dobritzsch, D., Meijer, J., Meinsma, R., Benoist, J., Assmann, B. E., Schubert‐Bast, S., Hoffmann, G. F., Durán, M., de Vries, M. C., et al. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.03.013 · Cited by 80
Ueda, M., Iguchi, T., Masuda, T., Nakahara, Y., Hirata, H., Uchi, R., Niida, A., Momose, K., Sakimura, S., Chiba, K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11409 · Cited by 77
Preimplantation Genetic Diagnosis for Cancer Syndromes
Offit, K., Sagi, M., & Hurley, K. E. (2006) · JAMA · doi:10.1001/jama.296.22.2727 · Cited by 76
Cited by
Artificial intelligence in healthcare
Yu, K.-H., Beam, A. L., & Kohane, I. S. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0305-z · Cited by 2,817
Next-Generation Sequencing Technology: Current Trends and Advancements
Satam, H., Joshi, K., Mangrolia, U., Waghoo, S., Zaidi, G., Rawool, S., Thakare, R. P., Banday, S., Mishra, A. K., Das, G., et al. (2023) · Biology · doi:10.3390/biology12070997 · Cited by 1,299
“NGS has facilitated the identification and characterization of these extended sets of genes associated with HBOC, expanding our knowledge of hereditary cancer predisposition [197].”
BackgroundProstate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A., & Mashele, S. (2022) · Molecules · doi:10.3390/molecules27175730 · Cited by 904
A deep learning model to predict RNA-Seq expression of tumours from whole-slide images
Schmauch, B., Romagnoni, A., Pronier, E., Saillard, C., Maillé, P., Calderaro, J., Kamoun, A., Sefta, M., Toldo, S., Zaslavskiy, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17678-4 · Cited by 533
[Retracted] Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures
Kashyap, D., Pal, D., Sharma, R., Garg, V. K., Goel, N., Koundal, D., Zaguia, A., Koundal, S., & Belay, A. (2022) · BioMed Research International · doi:10.1155/2022/9605439 · Cited by 529
Retracted
Metadata
- Authors
- Kamps, R., Brandão, R., Bosch, B., Paulussen, A., Xanthoulea, S., Blok, M., & Romano, A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-01-31
- Volume
- 18
- Issue
- 2
- Pages
- 308
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2585769337
- Cited by
- 453
- References
- 279
- FWCI
- 14.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.